CD47 is a potent Don’t eat me signal that enables cancer cells to evade immune surveillance and killing by innate immune cells, such as macrophages.
By using bispecific antibodies with a high affinity targeting arm (against a tumor-associated antigen, or TAA) and an anti CD47 arm of an optimized low affinity, the Don’t eat me signal is blocked selectively on TAA-positive cells, leading to the effective engulfment and degradation of tumor cells by macrophages (left-hand part of the video).
Due to the absence of a tumor-specific targeting arm, a monovalent anti CD47 bsAb is unable to bind and block CD47, with tumor cells that can resist the attack of macrophages (right-hand part of the video).
Read our latest news
Nanolive is proud to be part of a research collaboration with leading virologists from the group of Olivier Schwartz at the Institut Pasteur in Paris. The latest research from Nanolive’s Deep Quantitative Biology department and the Institut Pasteur uses cutting-edge...
Presentation Nanolive is delighted to invite you to attend our upcoming presentation at the Cell Bio Meeting in Boston on December 4, 2023, from 10:15am to 11:00am in Theatre 1. During our talk, “High-content label-free imaging for live phenotypic insights and...
💫Visit our booth:The world’s leading cancer research minds will converge at the ESMO Congress 2023. We are thrilled to announce that Nanolive will be exhibiting there from October 20 to 23, at Booth #560 in Hall 5! Come and meet our team and discover the...
3D CELL EXPLORER
Budget-friendly, easy-to-use, compact solution for high quality non-invasive 4D live cell imaging
3D CELL EXPLORER-fluo
Multimodal Complete Solution: combine high quality non-invasive 4D live cell imaging with fluorescence